Celltrion
068270.KS
#657
Rank
โ‚น2.616 T
Marketcap
โ‚น12,631
Share price
0.00%
Change (1 day)
38.92%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): โ‚น245.23

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น250.82. In 2022 the company made an earnings per share (EPS) of โ‚น244.18 a decrease over its 2021 EPS that were of โ‚น290.14.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น245.230.43%
2022โ‚น244.18-15.84%
2021โ‚น290.1412.77%
2020โ‚น257.2870.79%
2019โ‚น150.6415.63%
2018โ‚น130.28-33.13%
2017โ‚น194.84141.17%
2016โ‚น80.798.28%
2015โ‚น74.6111.28%
2014โ‚น67.0516.37%
2013โ‚น57.62-67.42%
2012โ‚น176.8784.22%
2011โ‚น96.0162.13%
2010โ‚น59.2280.61%
2009โ‚น32.79-559.63%
2008-โ‚น7.13-123.16%
2007โ‚น30.80